Jeffrey Sevigny
Chief Medical Officer · Rapport Therapeutics, Inc.
Individual
- 2026
- Feb 4, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey Sevigny files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- Abraham Ceesay - $5.93M in RAPP purchases and sales in the last 12 months
- Krishnaswamy Yeleswaram - $4.46M in RAPP purchases and sales in the last 12 months
- Cheryl Gault - $1.24M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Sevigny?
Jeffrey Sevigny is a corporate insider, tracked as Chief Medical Officer of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeffrey Sevigny last file a Form 4?
The only primary Form 4 on record is dated 4 February 2026.